Co-existence of BRAF^V600E and TERT promoter mutations in papillary thyroid carcinoma is associated with tumor aggressiveness, but not with lymph node metastasis

References

• PellegritiGFrascaFRegalbutoCSquatritoSVigneriRWorldwide increasing incidence of thyroid cancer: update on epidemiology and risk factorsJ Cancer Epidemiol2013201396521223737785
   PubMedGoogle Scholar
• LloydRVORKlöppelGRosaiJWHO Classification of Tumours of Endocrine Organs4th edLyon, FranceIARC Press2017
   Google Scholar
• DaviesLWelchHGIncreasing incidence of thyroid cancer in the United States, 1973–2002JAMA2006295182164216716684987
   PubMed Web of Science ®Google Scholar
• ChoSWChoiHSYeomGJLong-term prognosis of differentiated thyroid cancer with lung metastasis in Korea and its prognostic factorsThyroid201424227728623758653
   PubMed Web of Science ®Google Scholar
• XingMBRAF mutation in thyroid cancerEndocr Relat Cancer200512224526215947100
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research NIntegrated genomic characterization of papillary thyroid carcinomaCell2014159367669025417114
   PubMed Web of Science ®Google Scholar
• DaviesHBignellGRCoxCMutations of the BRAF gene in human cancerNature2002417689294995412068308
   PubMed Web of Science ®Google Scholar
• XingMAlzahraniASCarsonKAAssociation between BRAF V600E mutation and mortality in patients with papillary thyroid cancerJAMA2013309141493150123571588
   PubMed Web of Science ®Google Scholar
• XingMBRAF Mutation and Thyroid Cancer RecurrenceJ Clin Oncol201533222482248326124474
   PubMed Web of Science ®Google Scholar
• TufanoRPTeixeiraGVBishopJCarsonKAXingMBRAF mutation in papillary thyroid cancer and its value in tailoring initial treatment: a systematic review and meta-analysisMedicine201291527428622932786
   PubMed Web of Science ®Google Scholar
• TroviscoVSoaresPPretoAType and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients’ age but not with tumour aggressivenessVirchows Arch2005446658959515902486
   PubMed Web of Science ®Google Scholar
• FugazzolaLPuxedduEAveniaNCorrelation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literatureEndocr Relat Cancer200613245546416728573
   PubMed Web of Science ®Google Scholar
• NamJKJungCKSongBJIs the BRAF(V600E) mutation useful as a predictor of preoperative risk in papillary thyroid cancer?Am J Surg2012203443644121803329
   PubMed Web of Science ®Google Scholar
• KirkpatrickKLMokbelKThe significance of human telomerase reverse transcriptase (hTERT) in cancerEur J Surg Oncol200127875476011735173
   PubMedGoogle Scholar
• MeloMda RochaAGVinagreJTERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomasJ Clin Endocrinol Metab2014995E754E76524476079
   PubMed Web of Science ®Google Scholar
• XingMLiuRLiuXBRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrenceJ Clin Oncol201432252718272625024077
   PubMed Web of Science ®Google Scholar
• GeorgeJRHendersonYCWilliamsMDAssociation of TERT promoter mutation, but not BRAF mutation, with increased mortality in PTCJ Clin Endocrinol Metab201510012E1550E155926461266
   PubMed Web of Science ®Google Scholar
• NasirdenASaitoTFukumuraYIn Japanese patients with papillary thyroid carcinoma, TERT promoter mutation is associated with poor prognosis, in contrast to BRAF V600E mutationVirchows Arch2016469668769627718012
   PubMed Web of Science ®Google Scholar
• LiuTWangNCaoJThe age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomasOncogene201433424978498424141777
   PubMed Web of Science ®Google Scholar
• LeeSEHwangTSChoiYLPrognostic significance of TERT promoter mutations in papillary thyroid carcinomas in a BRAF(V600E) mutation-prevalent populationThyroid201626790191027184112
   PubMed Web of Science ®Google Scholar
• LiuXQuSLiuRTERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancerJ Clin Endocrinol Metab2014996E1130E113624617711
   PubMed Web of Science ®Google Scholar
• JinLBRAF and TERT promoter mutations in the aggressiveness ofpapillary thyroid carcinoma: a study of 653 patientsOncotarget2016714183461835526943032
   PubMed Web of Science ®Google Scholar
• LiuXBishopJShanYHighly prevalent TERT promoter mutations in aggressive thyroid cancersEndocr Relat Cancer201320460361023766237
   PubMed Web of Science ®Google Scholar
• AminMBESGreeneFLByrdDRBrooklandRKWashingtonMKAJCC Cancer Staging Manual8th edNew YorkSpringer International2017
   Google Scholar
• AsmannYWSunJZhangJBRAF V600E and TERT promoter mutations in papillary thyroid carcinoma in Chinese patientsPLoS One2016114e015331927064992
   PubMed Web of Science ®Google Scholar
• SongYSLimJAChoiHPrognostic effects of TERT promoter mutations are enhanced by coexistence with BRAF or RAS mutations and strengthen the risk prediction by the ATA or TNM staging system in differentiated thyroid cancer patientsCancer201612291370137926969876
   PubMed Web of Science ®Google Scholar
• MatsuseMYabutaTSaenkoVTERT promoter mutations and Ki-67 labeling index as a prognostic marker of papillary thyroid carcinomas: combination of two independent factorsSci Rep201774175228150740
   PubMed Web of Science ®Google Scholar
• HongARLimJAKimTHThe frequency and clinical implications of the BRAF(V600E) mutation in papillary thyroid cancer patients in Korea over the past two decadesEndocrinol Metab (Seoul)201429450551325325273
   PubMedGoogle Scholar
• LiuSZhangBZhaoYAssociation of BRAFV600E mutation with clinicopathological features of papillary thyroid carcinoma: a study on a Chinese populationInt J Clin Exp Pathol20147106922692825400776
   PubMed Web of Science ®Google Scholar
• ItoYYoshidaHMaruoRBRAF mutation in papillary thyroid carcinoma in a Japanese population: its lack of correlation with high-risk clinicopathological features and disease-free survival of patientsEndocr J2009561899718840924
   PubMed Web of Science ®Google Scholar
• GuerraAFugazzolaLMarottaVA high percentage of BRAFV600E alleles in papillary thyroid carcinoma predicts a poorer outcomeJ Clin Endocrinol Metab20129772333234022508706
   PubMed Web of Science ®Google Scholar
• ZengRCJinLPChenEDPotential relationship between Hashimoto’s thyroiditis and BRAF(V600E) mutation status in papillary thyroid cancerHead Eck201638Suppl 1E1019E1025
   PubMedGoogle Scholar
• KimSJMyongJPJeeHGCombined effect of Hashimoto’s thyroiditis and BRAF(V600E) mutation status on aggressiveness in papillary thyroid cancerHead Neck20163819510125213729
   PubMed Web of Science ®Google Scholar
• KimSKSongKHLimSDClinical and pathological features and the BRAF(V600E) mutation in patients with papillary thyroid carcinoma with and without concurrent Hashimoto thyroiditisThyroid200919213714119014278
   PubMed Web of Science ®Google Scholar
• MarottaVGuerraAZatelliMCBRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimoto’s thyroiditis lymphocytic infiltration is presentClin Endocrinol (Oxf)201379573373823469895
   PubMed Web of Science ®Google Scholar
• KimSKWooJWLeeJHChronic lymphocytic thyroiditis and BRAF V600E in papillary thyroid carcinomaEndocr Relat Cancer2016231273426598713
   PubMed Web of Science ®Google Scholar
• SongYSLimJAParkYJMutation profile of well-differentiated thyroid cancer in AsiansEndocrinol Metab (Seoul)201530325226226435130
   PubMedGoogle Scholar
• VuongHGAltibiAMADuongUNPHassellLPrognostic implication of BRAF and TERT promoter mutation combination in papillary thyroid carcinoma-A meta-analysisClin Endocrinol (Oxf)201787541141728666074
   PubMed Web of Science ®Google Scholar
• MoonSSongYSKimYAEffects of coexistent BRAFV600E and TERT promoter mutations on poor clinical outcomes in papillary thyroid cancer: a meta-analysisThyroid201727565166028181854
   PubMed Web of Science ®Google Scholar
• HornSFiglARachakondaPSTERT promoter mutations in familial and sporadic melanomaScience2013339612295996123348503
   PubMed Web of Science ®Google Scholar
• VinagreJAlmeidaAPopuloHFrequency of TERT promoter mutations in human cancersNature commun20134218523887589
   PubMed Web of Science ®Google Scholar
• RohJLKimJMParkCICentral lymph node metastasis of unilateral papillary thyroid carcinoma: patterns and factors predictive of nodal metastasis, morbidity, and recurrenceAnn Surg Oncol20111882245225021327454
   PubMed Web of Science ®Google Scholar
• LimYSLeeJCLeeYSLateral cervical lymph node metastases from papillary thyroid carcinoma: predictive factors of nodal metastasisSurgery2011150111612121507446
   PubMed Web of Science ®Google Scholar
• YoonJHLeeHSKimEKShort-term follow-up US leads to higher false-positive results without detection of structural recurrences in PTMCMedicine2016951e243526735548
   PubMed Web of Science ®Google Scholar
• de BiaseDGandolfiGRagazziMTERT promoter mutations in papillary thyroid microcarcinomasThyroid20152591013101926148423
   PubMed Web of Science ®Google Scholar